Pfizer sets sights on elimination of blinding disease trachoma by 2030 Ruchika Sharma26 Jun 2022 9:00 AM ISTThe ITI had initially hoped to eliminate the disease by 2020, but is now setting its sights on 2030.
Pfizer sued for patent infringement over Paxlovid Roshni Dhar25 Jun 2022 5:30 PM ISTPfizer Inc's blockbuster COVID-19 treatment Paxlovid violates an Enanta Pharmaceuticals Inc patent for its COVID drug still in development, according...
Health Bulletin 25/June/2022 Roshni Dhar25 Jun 2022 4:34 PM ISTHere are the top health stories for the day:Every harm, intimidation, obstruction or hindrance to healthcare professionals is violence: Kerala...
Pfizer sued for patent infringement over COVID-19 drug Paxlovid Ruchika Sharma24 Jun 2022 12:35 PM ISTEnanta requested an unspecified amount of money damages from Pfizer, including royalties.
Pfizer, Truveta join hands to accelerate safety insights in real time Ruchika Sharma22 Jun 2022 4:00 PM ISTBellevue: Truveta has announced a strategic collaboration with Pfizer to deliver new safety insights on a continuous basis, using verifiable...
Pfizer to acquire 8.1 percent stake in Valneva Ruchika Sharma20 Jun 2022 10:30 AM ISTValneva is planning to use the proceeds from Pfizer's equity investment to support its Phase 3 development contribution to the Lyme disease program.
Walmart, pharmacy chains plan to vaccinate young children with COVID shots after authorization Ruchika Sharma19 Jun 2022 10:00 AM ISTA spokesperson for Walmart said the retail giant and its unit Sam's Club plan to begin vaccinating children as young as 3.
Pfizer, Moderna COVID vaccines get USFDA emergency use nod for kids as young as 6 months MD Bureau18 Jun 2022 12:30 PM ISTThe FDA said its evaluation and analysis of the safety, effectiveness and manufacturing data of these vaccines was rigorous and comprehensive,...
Pfizer halts COVID drug Paxlovid trial for standard-risk population Ruchika Sharma16 Jun 2022 2:47 PM ISTThe new data, however, showed a 51% relative risk reduction in standard-risk groups, which the company said was not statistically significant.
CCI nod to acquisition of Corporate restructuring of GlaxoSmithKline Consumer Healthcare Holdings (JVCO) Ruchika Sharma15 Jun 2022 2:15 PM ISTNew Delhi: The Competition Commission of India (CCI) approves acquisition of Corporate restructuring of GlaxoSmithKline Consumer Healthcare Holdings...
Pfizer, MorphoSys and Incyte enter trial collaboration for Monjuvi in combination with TTI-622 Ruchika Sharma15 Jun 2022 10:00 AM ISTUnder the terms of the agreement, Pfizer will initiate a multicenter, international Phase 1b/2 study of TTI-622 with Monjuvi and lenalidomide for...
Pfizer-BioNTech COVID vaccines effective, safe for children aged 6 months to 4 years: USFDA staff Ruchika Sharma13 Jun 2022 1:45 PM ISTAn early analysis of data from Pfizer-BioNTech's vaccine based on 10 symptomatic COVID-19 cases identified when the Omicron coronavirus variant was...
